I read this as additional revenue to the US$100M from the presentation.
That referred to integration with PDX pharmacies - Albertsons, Weis, Giant Eagle and Lunds & Byerlys etc.
This appears to be a seperate opportunity.
Which suggests we’re still due the PDX announcement next month.
It has taken them a good 12 months to build MedAdvisor to be compliant with US regulations. It is next month that they can’t start to commercialise the platform through PDX.
With revenues to start arriving in Q3 2019 through Adheris it looks like they can leverage all the work that started with PDX.
I read this as additional revenue to the US$100M from the...
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $80.26K | 285.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11778 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 9912 | 2 |
View Market Depth
| Last trade - 12.39pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
